BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28303897)

  • 1. Synergistic efficacy of Bisbenzimidazole and Carbonyl Cyanide 3-Chlorophenylhydrazone combination against MDR bacterial strains.
    Sinha D; Pandey S; Singh R; Tiwari V; Sad K; Tandon V
    Sci Rep; 2017 Mar; 7():44419. PubMed ID: 28303897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic Antimicrobial Activity of Colistin in Combination with Rifampin and Azithromycin against Escherichia coli Producing MCR-1.
    Li Y; Lin X; Yao X; Huang Y; Liu W; Ma T; Fang B
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPEF: A bisbenzimdazole potent antimicrobial agent interacts at acidic triad of catalytic domain of E. coli topoisomerase IA.
    Singh R; Pandey S; Sur S; Tandon V
    Biochim Biophys Acta Gen Subj; 2019 Oct; 1863(10):1524-1535. PubMed ID: 31145964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of carbonyl cyanide-3-chlorophenylhydrazone on biofilm formation and antimicrobial resistance in Pseudomonas aeruginosa using quantum dots-meropenem conjugates as nanotools.
    Silva Júnior VV; Raposo BL; Lopes ACS; Araújo PSR; Fontes A; Cabral Filho PE; Maciel MAV
    Methods Appl Fluoresc; 2020 Oct; 8(4):045005. PubMed ID: 33021210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling topoisomerase IA gate dynamics in presence of PPEF and its preclinical evaluation against multidrug-resistant pathogens.
    Maurya V; Singh R; Singh RK; Pandey S; Yadav P; Parashar P; Gaind R; Dubey KD; Naresh Patwari G; Tandon V
    Commun Biol; 2023 Feb; 6(1):195. PubMed ID: 36807602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of Escherichia coli.
    Paltansing S; Tengeler AC; Kraakman ME; Claas EC; Bernards AT
    Microb Drug Resist; 2013 Dec; 19(6):469-76. PubMed ID: 23909485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Butenolide, a Marine-Derived Broad-Spectrum Antibiofilm Agent Against Both Gram-Positive and Gram-Negative Pathogenic Bacteria.
    Yin Q; Liang J; Zhang W; Zhang L; Hu ZL; Zhang Y; Xu Y
    Mar Biotechnol (NY); 2019 Feb; 21(1):88-98. PubMed ID: 30612218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL
    Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
    Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
    Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Efflux Pump Inhibitors on the Activity of Selected Non-Antibiotic Medicinal Products against Gram-Negative Bacteria.
    Laudy AE; Kulińska E; Tyski S
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28085074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of novel bisbenzimidazoles as Escherichia coli topoisomerase IA inhibitors and potential antibacterial agents.
    Nimesh H; Sur S; Sinha D; Yadav P; Anand P; Bajaj P; Virdi JS; Tandon V
    J Med Chem; 2014 Jun; 57(12):5238-57. PubMed ID: 24856410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Pharmacodynamic Target Investigation of Two Bacterial Topoisomerase Inhibitors, ACT-387042 and ACT-292706, in the Neutropenic Murine Thigh Model against Streptococcus pneumoniae and Staphylococcus aureus.
    Lepak AJ; Seiler P; Surivet JP; Ritz D; Kohl C; Andes DR
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3626-32. PubMed ID: 27044547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The action of Pseudomonas aeruginosa biofilms in intrinsic drug resistance.
    Xie Y; Jia WX; Zeng W; Yang WQ; Cheng X; Li XR; Wang LL; Kang M; Zhang ZR
    Chin Med J (Engl); 2005 Oct; 118(19):1615-22. PubMed ID: 16232346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental Evolution of Escherichia coli K-12 in the Presence of Proton Motive Force (PMF) Uncoupler Carbonyl Cyanide
    Griffith JM; Basting PJ; Bischof KM; Wrona EP; Kunka KS; Tancredi AC; Moore JP; Hyman MRL; Slonczewski JL
    Appl Environ Microbiol; 2019 Mar; 85(5):. PubMed ID: 30578262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The specific effect of (R)-(+)-pulegone on growth and biofilm formation in multi-drug resistant Escherichia coli and molecular mechanisms underlying the expression of pgaABCD genes.
    Gong H; He L; Zhao Z; Mao X; Zhang C
    Biomed Pharmacother; 2021 Feb; 134():111149. PubMed ID: 33385683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009].
    Hamouche E; Sarkis DK
    Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enterohemorrhagic Escherichia coli biofilms are inhibited by 7-hydroxyindole and stimulated by isatin.
    Lee J; Bansal T; Jayaraman A; Bentley WE; Wood TK
    Appl Environ Microbiol; 2007 Jul; 73(13):4100-9. PubMed ID: 17483266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combatting bacterial infections by killing persister cells with mitomycin C.
    Kwan BW; Chowdhury N; Wood TK
    Environ Microbiol; 2015 Nov; 17(11):4406-14. PubMed ID: 25858802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing approved drugs as potential efflux pump inhibitors in multidrug-resistant
    de Melo Guedes GM; Pereira VC; Freitas AS; Honório de Souza PR; Chacon Parra AL; Brasil JA; de Medeiros Guedes RF; Pereira de Sousa PC; Aguiar Cordeiro R; Gadelha Rocha MF; Costa Sidrim JJ; Souza Collares Maia Castelo Branco D
    Future Microbiol; 2024; 19(6):495-508. PubMed ID: 38629920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Pseudomonas aeruginosa by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers.
    Howard JJ; Sturge CR; Moustafa DA; Daly SM; Marshall-Batty KR; Felder CF; Zamora D; Yabe-Gill M; Labandeira-Rey M; Bailey SM; Wong M; Goldberg JB; Geller BL; Greenberg DE
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.